Industry reports
Editor highlights

Partnering Deals and Alliances with Big Pharma

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 41 pages

A textual analysis of the financial results for Cell Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Therapy

Cesca Therapeutics Inc

Cesca Therapeutics Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 41 pages

A textual analysis of the financial results for Cesca Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Therapy

Five Prime Therapeutics Inc

Five Prime Therapeutics Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 36 pages

A textual analysis of the financial results for Five Prime Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Protalix Biotherapeutics Inc

Protalix Biotherapeutics Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 42 pages

A textual analysis of the financial results for Protalix Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Stemline Therapeutics Inc

Stemline Therapeutics Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 37 pages

A textual analysis of the financial results for Stemline Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Opexa Therapeutics, Inc.

Opexa Therapeutics, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 41 pages

A textual analysis of the financial results for Opexa Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Hyperion Therapeutics Inc

Hyperion Therapeutics Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 38 pages

A textual analysis of the financial results for Hyperion Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Silence Therapeutics Plc

Silence Therapeutics Plc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 42 pages

A textual analysis of the financial results for Silence Therapeutics Plc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Manhattan Scientifics, Inc.

Manhattan Scientifics, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 41 pages

A textual analysis of the financial results for Manhattan Scientifics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Sorrento Therapeutics, Inc. (Symbol:SRNE) SWOT Analysis, Strategy, Revenues and Profits

Sorrento Therapeutics, Inc. (Symbol:SRNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Sorrento Therapeutics, Inc. SWOT Analysis report provides you a strategic ...

Industries: Therapy

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.